Search IPOs
AGARWALEYE · NSE,BSE · Healthcare Services
Dr.Agarwal's Health Care IPO listed on 04 Feb 2025 on NSE,BSE at ₹402.00, a gain of 0.00% over the issue price of ₹402.00. The IPO was subscribed 1.55x overall.
Dr.Agarwal's Health Care IPO tentative timeline covering IPO opening, closing, basis of allotment, refunds, demat credit, and listing dates.
| Event | Date |
|---|---|
| IPO Open Date | 29 Jan 2025 |
| IPO Close Date | 31 Jan 2025 |
| Basis of Allotment | 03 Feb 2025 |
| Initiation of Refunds | 04 Feb 2025 |
| Credit of Shares to Demat | 04 Feb 2025 |
| Listing Date | 04 Feb 2025 |
Listing day gain
+0%
Listed at ₹402 (issue ₹402)
Issue
₹402
Listing
₹402
Current
₹401.65
-0.09% vs issue
Day range
₹370.2 – ₹412.9
Issue Size
75,304,970 shares
(aggregating up to ₹3,027.26 Cr)
Issue Price
₹382 – ₹402
Face Value
₹1/share
Market Lot
35 shares
Retail Min Investment
₹14,070
Listing At
NSE,BSE
Sale Type
both
Fresh Issue
7,462,686 shares
(aggregating up to ₹300 Cr)
Offer for Sale
67,842,284 shares
(aggregating up to ₹2,727.26 Cr)
Issue Type
book building
Open Date
29 Jan
Close Date
31 Jan
Allotment
03 Feb
Listing
04 Feb
Last updated: 1 year ago
| Date | IPO Issue Price (₹) | GMP (₹) | Est. Listing Price (₹) | Est. Profit Amount (₹) | Est. Profit % | Last Updated |
|---|---|---|---|---|---|---|
| 05 Feb 2025 Latest | ₹402 | ₹-4 | ₹398 | ₹-4 |
-1%
|
12:00 AM |
| 04 Feb 2025 | ₹402 | ₹-4 | ₹398 | ₹-4 |
-1%
|
12:00 AM |
Showing the 2 most recent GMP entries.
View full GMP historyLatest snapshot: 31 Jan 2025
| Category | Subscribed (x) |
|---|---|
| QIB | 4.64x |
| NII | 0.4x |
| bNII (bids above ₹10L) | 0.31x |
| sNII (bids below ₹10L) | 0.56x |
| Retail Investors | 0.41x |
| Shareholders | 0.52x |
| Employees | 0.27x |
| Total | 1.55x |
Showing the latest subscription snapshot.
View full subscription historyAmar Agarwal, Athiya Agarwal, Adil Agarwal, Anosh Agarwal, Ashvin Agarwal, Ashar Agarwal, Amar Agarwal Family Trust, Adil Agarwal Family Trust, Anosh Agarwal Family Trust, Ashvin Agarwal Family Trust, Ashar Agarwal Family Trust, DR.AGARWAL’S EYE INSTITUTE and Agarwal's Eye Institute Pvt.Ltd.
New to lot sizes and investment limits? Read our guide on IPO lot size and minimum investment.
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 35 | ₹14,070 |
| Retail (Max) | 14 | 490 | ₹196,980 |
| S-HNI (Min) | 15 | 525 | ₹211,050 |
| S-HNI (Max) | 71 | 2,485 | ₹998,970 |
| B-HNI (Min) | 72 | 2,520 | ₹1,013,040 |
| Application Category | Maximum Bidding Limits | Bidding at Cut-off Price Allowed |
|---|---|---|
| Only employee | 2 | No |
Want to understand how IPO shares are divided between investor categories? Read our guide on IPO reservation structure.
| Category | Shares Offered |
|---|---|
| QIB Shares Offered | 36,297,998 (48.20%) |
|
•
Anchor Investor Shares Offered
|
21,778,798 (28.92%) |
|
•
QIB (Ex. Anchor) Shares Offered
|
14,519,200 (19.28%) |
| NII (HNI) Shares Offered | 10,889,400 (14.46%) |
|
•
bNII > ₹10L
|
7,259,600 (9.64%) |
|
•
sNII < ₹10L
|
3,629,800 (4.82%) |
| Retail Shares Offered | 25,408,599 (33.74%) |
| Employee | 1,579,399 (2.10%) |
| Shareholders Shares Offered | 1,129,574 (1.50%) |
| Total Shares Offered | 75,304,970 (100.00%) |
Dr. Agarwal’s Health Care Limited is a premier eye care network delivering comprehensive ophthalmic solutions across India and international markets. Established with a legacy of excellence, the group operates an expansive chain of eye hospitals and clinics—offering specialized treatments including cataract procedures, refractive surgeries, cornea transplants, advanced diagnostics, and optical care products.
The Dr. Agarwal’s Health Care Ltd. IPO represents a significant milestone in the healthcare delivery sector. With an issue size of ₹3,027.26 Crore, the public offer consists of a fresh issue of ₹300 Crore alongside an Offer for Sale (OFS) by existing shareholders. The net proceeds from the fresh issue aim to support debt repayment, clinical network expansion, and strategic growth initiatives.
Standalone · ₹ in Crores
| Particulars | FY 2022 | FY 2023 | FY 2024 |
|---|---|---|---|
| Total Revenue | 713.78 | 1,031.49 | 837.94 |
| Profit After Tax (PAT) | 43.16 | 103.23 | 39.56 |
| EBITDA | - | - | - |
| Total Assets | 1,026.13 | 1,825.17 | 3,393.41 |
| Net Worth | 212.34 | 627.83 | 1,502.67 |
| Reserves & Surplus | 236.27 | 652.63 | 1,509.11 |
| Total Borrowing | 290.18 | 356.18 | 373.68 |
Revenue & Profit Trend
Key ratios per fiscal period
| Particulars | Mar 2024 |
|---|---|
| RoE Return on Equity Shows how much profit the company makes on the money shareholders have put in. 15% to 20% is healthy in most industries. | 9.33% |
| RoCE Return on Capital Employed Shows the profit earned on all the money used, shareholder funds plus loans. Matters most for factory and infrastructure heavy companies. | 14.61% |
| RoNW Return on Net Worth Shows the profit earned on the company's own net worth. Steady or rising over 3 years is a good sign. | 6.21% |
| PAT Margin Profit After Tax Margin Out of every ₹100 of sales, how much the company keeps after paying all costs, loan interest and tax. | 6.9% |
| P/BV Price to Book Value Tells you if the IPO price is above what the company actually owns. 1x to 3x is usually seen as reasonable. | 7.96x |
Issue-level · at the upper price band
| Particulars | Pre-IPO | Post-IPO |
|---|---|---|
| EPS Earnings Per Share Profit the company earns on each share. Post-IPO EPS is usually lower because the issue adds new shares. | ₹3.08 | ₹2.51 |
| P/E Price to Earnings Tells you if the IPO price is fair for what the company earns. Compare it with listed companies in the same sector. | 130.44x | 160.48x |
| Market Cap Market Capitalisation What the whole company is valued at, at the upper price band. Post-IPO counts the new shares the issue creates. | ₹12,398 Cr | ₹12,687 Cr |
The basis of allotment for Dr.Agarwal's Health Care IPO was finalised on 03 Feb 2025. You can check your allotment status using your PAN number or application number on the KFin Technologies Limited portal or BSE.
The Dr.Agarwal's Health Care IPO is expected to open in Jan 2025, subject to SEBI approval. Final dates will be updated once announced officially.
The price band for Dr.Agarwal's Health Care IPO is ₹382.00 - ₹402.00 per share.
As per market sources, Dr.Agarwal's Health Care IPO GMP is currently ₹-4.00. GMP is tracked daily in the grey market. GMP indicates unofficial demand but does not guarantee listing gains.
The subscription status for Dr.Agarwal's Health Care IPO stands at 1.55x overall.
The listing date for Dr.Agarwal's Health Care IPO is 04 Feb 2025.
No comments yet. Be the first to comment!
